dc.creatorGómez Beltrán, David Alberto
dc.creatorVillar Argaiz, David
dc.creatorLópez Osorio, Sara
dc.creatorFerguson, Duncan C.
dc.creatorMonsalve, Laura K.
dc.creatorChaparro Gutiérrez, Jenny Jovana
dc.date2022-04-29T20:53:20Z
dc.date2022-04-29T20:53:20Z
dc.date2020
dc.date.accessioned2023-08-28T20:57:57Z
dc.date.available2023-08-28T20:57:57Z
dc.identifierhttp://hdl.handle.net/10495/28029
dc.identifier10.3390/vetsci7040173
dc.identifier2306-7381
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8486724
dc.descriptionABSTRACT: The susceptibility to antimicrobials of bacterial isolates from dogs (n = 1256) and cats (n = 94) was retrospectively evaluated in a veterinary diagnostic laboratory over a 4-year period (2016–2019). Out of 1316 isolates in dogs, 771 were Staphylococcus spp. distributed as follows: Staph. pseudointermedius (n = 406), Staph. intermedius (n = 160), Staph. aureus (n = 104), and Staph. coagulase-negative (n = 101). In common, all Staphylococcus spp. showed a high prevalence (20–50%) of resistance to ampicillin, cephalosporin, enrofloxacin, gentamicin, tetracycline, and trimethoprim-sulfonamide, but a low prevalence (1–10%) of resistance to amoxicillin-clavulanate. With regards to the other families of bacteria, the number of antimicrobials for which resistance was high (>20%) in dogs was: Enterobacteriaceae (7/12), Enterococcus spp. (10/16), E. coli (11/15), Pseudomonas spp. (10/13), and Streptococcus spp. (4/9). For urinary tract infections caused by E. coli or Enterobacteriaceae (Klebsiella spp., Proteus spp.), amikacin and florfenicol were the only drugs that demonstrated 100% in vitro e cacy. Multi-drug resistance was observed in 18.7% (246/1316) and 22% (21/97) of the isolates from dogs and cats, respectively. Except for Pseudomonas spp., known for intrinsic resistance, resistance in other bacteria was likely attributed to high selection pressure. In conclusion, empirical antimicrobial use cannot be recommended to treat most common infections, and selection should be based on results from susceptibility testing.
dc.descriptionCOL0153246
dc.format11
dc.formatapplication/pdf
dc.formatapplication/pdf
dc.languageeng
dc.publisherMDPI
dc.publisherCentro de Investigaciones Básicas y Aplicadas en Veterinaria (CIBAV)
dc.publisherBasilea, Suiza
dc.relationVet. Sci.
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttps://creativecommons.org/licenses/by/2.5/co/
dc.rightshttp://purl.org/coar/access_right/c_abf2
dc.rightshttps://creativecommons.org/licenses/by/4.0/
dc.subjectColombia
dc.subjectResistencia a Medicamentos
dc.subjectDrug Resistance
dc.subjectPerros
dc.subjectDogs
dc.subjectGatos
dc.subjectCats
dc.subjectResistencia a Múltiples Medicamentos
dc.subjectDrug Resistance, Multiple
dc.titlePrevalence of Antimicrobial Resistance in Bacterial Isolates from Dogs and Cats in a Veterinary Diagnostic Laboratory in Colombia from 2016–2019
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typehttp://purl.org/coar/resource_type/c_2df8fbb1
dc.typehttps://purl.org/redcol/resource_type/ART
dc.typeArtículo de investigación


Este ítem pertenece a la siguiente institución